Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
MMWR. Morbidity and mortality weekly report, Vol. 62, no. 23, June 14, 2013
Filetype[PDF-997.65 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. MMWR. Morbidity and mortality weekly report, Vol. 62, no. 24, June 21, 2013
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    June 21, 2013
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 62, no. 24
    Description:
    Nationwide Rubella Epidemic — Japan, 2013 -- Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for Injecting Drug Users -- Mass Drug Administration for the Elimination of Lymphatic Filariasis â€...
    File Type:
    Filetype[PDF - 641.10 KB]
  2. MMWR. Morbidity and mortality weekly report, Vol. 62, no. 25, June 28, 2013
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    June 28, 2013
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 62, no. 25
    Description:
    Nationwide Rubella Epidemic — Japan, 2013 -- Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for Injecting Drug Users -- Mass Drug Administration for the Elimination of Lymphatic Filariasis â€...
    File Type:
    Filetype[PDF - 529.16 KB]
  3. MMWR. Morbidity and mortality weekly report, Vol. 62, no. 8, March 1, 2013
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    March 1, 2013
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 62, no. 8
    Description:
    Nationwide Rubella Epidemic — Japan, 2013 -- Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for Injecting Drug Users -- Mass Drug Administration for the Elimination of Lymphatic Filariasis â€...
    File Type:
    Filetype[PDF - 679.88 KB]
  4. Summary of notifiable infectious diseases and conditions -- United States, 2013
    Personal Author:
    Adams, Deborah A.; Fullerton, Kathleen E.; Jajosky, Ruth A.; Sharp, Pearl; Onweh, Diana H.; Schley, Alan W.; Anderson, Willie J.; Faulkner, Amanda; Kugeler, Kiersten J.;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Nationally Notifiable Infectious Conditions Group.. Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. Division of Health Informatics and Surveillance.. National Center for Emerging and Zoonotic Infectious Diseases (U.S.), Division of Foodborne, Waterborne and Environmental Diseases.. National Center for Immunization and Respiratory Diseases (U.S.), Division of Bacterial Diseases.. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases..
    Published Date:
    October 23, 2015
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 62, no. 53
    National Notifiable Diseases: Infectious Annual Tables 2013
    Description:
    Nationwide Rubella Epidemic — Japan, 2013 -- Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for Injecting Drug Users -- Mass Drug Administration for the Elimination of Lymphatic Filariasis â€...
    File Type:
    Filetype[PDF - 5.09 MB]
  5. MMWR. Morbidity and mortality weekly report, Vol. 62, no. 12, March 29, 2013
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    March 29, 2013
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 62, no. 12
    Description:
    Nationwide Rubella Epidemic — Japan, 2013 -- Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for Injecting Drug Users -- Mass Drug Administration for the Elimination of Lymphatic Filariasis â€...
    File Type:
    Filetype[PDF - 611.07 KB]